Sorrento Therapeutics Shares Spike To Session High, Now Up 10%, Amid Circulation Of Seeking Alpha Blog Post From Tues. 'Covid-19 Virus Spreads, Sorrento Therapeutics Stock Is A Buy Say Analysts Offering 1000% Upside'
Benzinga Newsdesk